Frequently Asked Questions

Signs may include:¹

• Tremor
• Slowed movement
• Rigid muscles
• Postural instability
• Speech changes
• Writing changes
• Nonmotor symptoms, like depression, anxiety, constipation and sleep problems.

1. Source: https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055

While every study is different, currently enrolling local studies are looking for individuals between the ages of 30 and 80 who:

• Have a confirmed diagnosis of Parkinson’s disease and a stable dose of Parkinson’s medication
• Experience “OFF” time daily (times when medications do not work)
• Can swallow oral medication tablets
• Are not currently and have not used any tobacco products in the last 6 months

Additional criteria apply. A study doctor will determine final eligibility based on full medical criteria.

The information gathered in clinical studies may help identify new treatment options in the future for people living with Parkinson’s disease. Study participants are often connected to specialists who understand their situation and can help answer questions from patients or their loved ones. Participants in research studies should expect to experience a professional clinical environment, be treated with compassion and respect, and have access to top quality study-related care during the clinical trial.

Most clinical trials will involve a screening visit to confirm that a potential patient is, in fact, a match for that study’s criteria. Once verified, an Informed Consent Form, which clearly provides the details and purpose of the study to that individual and what it involves, is reviewed with the patient to sign. Participants can then expect to attend scheduled appointments at a study clinician’s site. They may also receive a study treatment (also called an investigational product) or potentially a control (also known as placebo which contains no active treatment) and undergo additional assessments and follow-up monitoring. Throughout the study, participants should experience a professional clinical environment, and be treated with compassion and respect.

No. Current studies evaluate investigational treatments taken in addition to your standard anti-Parkinsons medications.

No, there is no cost to participate. For qualified participants who choose to be in this study, the study drug will be provided at no cost. There will be no charge for any tests, examinations, nor visits done as part of this study. Participants may be reimbursed for travel costs and out of pocket expenses or these costs may be covered directly. They may also receive compensation for their time and effort.

In any clinical study for a new treatment, there are potential risks, such as side effects of the study drug or risks from the study activities. The study staff will explain these potential risks before participants decide whether to participate, and address any concerns.

No. Before a potential participant decides whether to take part in the study, the study staff will review the informed consent form with them and answer any questions. Once the consent form has been signed by the participant, the screening period of the study begins. During this period, the staff will review medical history and conduct any relevant assessments. Participants who meet all of the study criteria will be invited to participate.

Yes. Participation in clinical trials is entirely voluntary. Even if a participant is already involved in a study, they may change their mind at any time, for any reason.

If you are interested in learning more, please contact us at any time. You may email us at help@clinicalenrollment.com.